{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:06:47Z","timestamp":1791436007770,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.ghir.2007.07.006","type":"journal-article","created":{"date-parts":[[2007,8,22]],"date-time":"2007-08-22T07:13:26Z","timestamp":1187766806000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"18","author":[{"given":"Eitetsu","family":"Tei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Nakadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobumasa","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2007.07.006_bib1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/archneur.56.11.1388","article-title":"The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease","volume":"56","author":"Mega","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ghir.2007.07.006_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00002093-200000001-00002","article-title":"Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer\u2019s disease","volume":"14 suppl 1","author":"Giacobini","year":"2000","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ghir.2007.07.006_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02257673","article-title":"The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer\u2019s disease","volume":"5","author":"Alhainen","year":"1993","journal-title":"J. Neural. Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.ghir.2007.07.006_bib4","first-page":"309","article-title":"Do blood pressure and age predict response to tacrine (THA) in Alzheimer\u2019s disease? A preliminary report","volume":"27","author":"Schneider","year":"1991","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.ghir.2007.07.006_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.50.3.669","article-title":"Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer\u2019s disease","volume":"50","author":"Farlow","year":"1998","journal-title":"Neurology"},{"issue":"Suppl.","key":"10.1016\/j.ghir.2007.07.006_bib6","first-page":"16","article-title":"Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy","volume":"149","author":"Alhainen","year":"1993","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ghir.2007.07.006_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/089198879600900101","article-title":"Effect of tacrine on behavioral symptoms in Alzheimer\u2019s disease: An open-label study","volume":"9","author":"Kaufer","year":"1996","journal-title":"J. Geriatr. Psychiat. Neurol."},{"key":"10.1016\/j.ghir.2007.07.006_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archneur.58.3.417","article-title":"Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression","volume":"58","author":"Farlow","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ghir.2007.07.006_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1176\/jnp.12.2.209","article-title":"Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer\u2019s disease","volume":"12","author":"Mega","year":"2000","journal-title":"J. Neuropsych. Clin. Neurosci."},{"key":"10.1016\/j.ghir.2007.07.006_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000070998","article-title":"Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer\u2019s disease patients","volume":"16","author":"Tanaka","year":"2003","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.ghir.2007.07.006_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000078625","article-title":"Efficacy of donepezil treatment in Alzheimer patients with and without subcortical vascular lesions","volume":"72","author":"Blasko","year":"2004","journal-title":"Pharmacology"},{"key":"10.1016\/j.ghir.2007.07.006_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-4580(02)00136-7","article-title":"Insulin-like growth factor I (IGF-I) and cognitive decline in older persons","volume":"24","author":"Dik","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ghir.2007.07.006_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000095803","article-title":"Association of insulin-like growth factor-1 receptor polymorphism in dementia","volume":"22","author":"Garcia","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.ghir.2007.07.006_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2004.02.050","article-title":"The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer\u2019s disease","volume":"490","author":"Carro","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ghir.2007.07.006_bib15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0166-2236(03)00163-2","article-title":"Potential roles of insulin and IGF-I in Alzheimer\u2019s disease","volume":"26","author":"Gasparini","year":"2003","journal-title":"Trend Neurosci."},{"key":"10.1016\/j.ghir.2007.07.006_bib16","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/j.1532-5415.2005.53524.x","article-title":"Relationship between serum insulin-like growth factor-1 levels and Alzheimer\u2019s disease and vascular dementia","volume":"53","author":"Watanabe","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ghir.2007.07.006_bib17","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0090-9556(24)14950-1","article-title":"Absorption, distribution, metabolism, and excretion of donepezil (aricept) after a single oral administration to rat","volume":"27","author":"Matsui","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ghir.2007.07.006_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019s disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J. Alzheimer Dis."},{"key":"10.1016\/j.ghir.2007.07.006_bib19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.ghir.2007.07.006_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ghir.2007.07.006_bib21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.ghir.2007.07.006_bib22","first-page":"653","article-title":"Functional assessment staging (FAST)","volume":"24","author":"Reisberg","year":"1988","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.ghir.2007.07.006_bib23","first-page":"1217","article-title":"Development of a new rating scale for dementia in the elderly: mental function impairment scale (MENFIS)","volume":"2","author":"Honma","year":"1991","journal-title":"Jap. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.ghir.2007.07.006_bib24","doi-asserted-by":"crossref","unstructured":"G.C. Roman, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings J.C. Masdeu, P. Scheinberg, Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop, Neurology, 43, 1993, pp. 250\u2013260.","DOI":"10.1212\/WNL.43.2.250"},{"key":"10.1016\/j.ghir.2007.07.006_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00002093-199903000-00004","article-title":"Assessment individual patients for cognitive benefits from acetylcholinesterase inhibitors","volume":"13","author":"Sands","year":"1999","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ghir.2007.07.006_bib26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1532-5415.2005.53204.x","article-title":"High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia","volume":"53","author":"Yamamoto","year":"2005","journal-title":"J. Am. Geriatric. Soc."},{"key":"10.1016\/j.ghir.2007.07.006_bib27","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0895-7061(03)00985-3","article-title":"Increased levels of insulin-like growth factor binding protein-3 in hypertensive patients with carotid atherosclerosis","volume":"16","author":"Watanabe","year":"2003","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ghir.2007.07.006_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ghir.2005.09.001","article-title":"The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis","volume":"15","author":"Arwert","year":"2005","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2007.07.006_bib29","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1210\/jcem.82.7.4087","article-title":"Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centanarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function","volume":"82","author":"Paolisso","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2007.07.006_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neurobiolaging.2005.10.012","article-title":"Plasma IGF-1 levels and cognitive performance in older women","volume":"28","author":"Okereke","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ghir.2007.07.006_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ghir.2006.11.001","article-title":"Free insulin-like growth factor-I and cognitive function in older persons living in community","volume":"17","author":"Landi","year":"2007","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2007.07.006_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0149-7634(00)00040-3","article-title":"Insulin receptors and insulin action in the brain review and clinical implications","volume":"24","author":"Schulingkamp","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ghir.2007.07.006_bib33","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1073\/pnas.91.21.10203","article-title":"Learning of the conditioned eye-blink response is impaired by an antisense insulin-like growth factor I oligonucleotide","volume":"91","author":"Castro-Alamancos","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2007.07.006_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0006-291X(92)91774-K","article-title":"A role for IGF-1 in the rescure of CNS neurons following hypoxic\/ischemic injury","volume":"182","author":"Gluckman","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ghir.2007.07.006_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/(SICI)1097-4652(199609)168:3<499::AID-JCP2>3.0.CO;2-K","article-title":"Activation of the I-LGF-1 receptor inhibits tumor necrosis factor-induced cell death","volume":"168","author":"Wu","year":"1996","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ghir.2007.07.006_bib36","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1202-793","article-title":"Serum insulin-like growth factor-I regulates brain amyroid-\u03b2 levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ghir.2007.07.006_bib37","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.neurobiolaging.2005.09.039","article-title":"Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer\u2019s-like neuropathology in rodents: new cues into the human disease?","volume":"27","author":"Carro","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ghir.2007.07.006_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signalling mechanisms in Alzheimer\u2019s disease-is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimer Dis."},{"key":"10.1016\/j.ghir.2007.07.006_bib39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000017188","article-title":"Decreased plasma insulin-like growth factor-I level in familial Alzheimer\u2019s disease patients carrying the Swedish APP 670\/671 mutation","volume":"10","author":"Mustafa","year":"1999","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.ghir.2007.07.006_bib40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neurobiolaging.2006.02.012","article-title":"Serum TNF-alpha levels are increased and correlated negatively with free IGF-I in Alzheimer disease","volume":"28","author":"Alvarez","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ghir.2007.07.006_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(99)00046-6","article-title":"Characterization of cytokine production screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer\u2019s disease individuals","volume":"97","author":"Lombardi","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ghir.2007.07.006_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000101062","article-title":"The relationship in Japanese infants between a genetic polymorphism in the promoter region of the insulin-like growth factor I gene and the plasma level","volume":"92","author":"Kinoshita","year":"2007","journal-title":"Neonatology"},{"key":"10.1016\/j.ghir.2007.07.006_bib43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ghir.2006.12.005","article-title":"Effect of topical application of capsaicin and its related compounds on dermal insulin-like growth factor-I levels in mice and on facial skin elasticity in humans","volume":"17","author":"Harada","year":"2007","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2007.07.006_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.exger.2004.11.001","article-title":"The age-related down-regulation of the growth hormone\/insulin-like growth factors-I axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer\u2019s disease","volume":"40","author":"Obermayr","year":"2005","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ghir.2007.07.006_bib45","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2007.07.006_bib46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/8756-3282(96)00017-8","article-title":"The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts","volume":"18","author":"Vignery","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.ghir.2007.07.006_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1160\/TH04-02-0106","article-title":"Contribution of capsaicin-sensitive sensory neurons to antithrombin-induced reduction of ischemia\/reperfusion-induced liver injury in rats","volume":"93","author":"Harada","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ghir.2007.07.006_bib48","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.neuropharm.2007.01.016","article-title":"Stimulation of sensory neurons by capsaicin increases tissue levels of IGF-I thereby reducing reperfusion-induced apoptosis in mice","volume":"52","author":"Harada","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ghir.2007.07.006_bib49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jns.2004.07.009","article-title":"Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer\u2019s disease","volume":"225","author":"Tanaka","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ghir.2007.07.006_bib50","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(06)68350-5","article-title":"Severe Alzheimer\u2019s disease study group, donepezil in patients with severe Alzheimer\u2019s disease: double bond, parallel-group, placebo-controlled study","volume":"367","author":"Winblad","year":"2006","journal-title":"Lancet"}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637407000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637407000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:43:45Z","timestamp":1761086625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637407000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S1096637407000925"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2007.07.006","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2007.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}